Oxford Biodynamics
Oxford
About Oxford Biodynamics
Oxford BioDynamics discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry.The Company’s award-winning, proprietary technology platform, EpiSwitch™, aims to accelerate the drug discovery and development process, improve the success rate of therap.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $51.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2025)
- Ticker: lse:OBD
- Website: oxfordbiodynamics.com
- Phone: +44 0 1865 518 910
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/oxford-biodynamics-2235682 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.